
SSAI statement supports the suspension of HES solutions by the EMA
The European Medicine Agency has decided to suspend Hydroxyethyl-Starch (HES) because of serious side-effects in specific patient groups: This decision has obviously led to some…

The European Medicine Agency has decided to suspend Hydroxyethyl-Starch (HES) because of serious side-effects in specific patient groups: This decision has obviously led to some…

The 29th of September 2018 the Department of Anaesthesiology and Intensive Care at Odense University Hospital in Denmark hosts the Symposium: Anaesthesia and Surgery in…

The Clinical Practice Committee of the SSAI has published a new guideline: “Scandinavian SSAI clinical practice guideline on choice of inotropic agent for patients with…

The department of Anaesthesia and Intensive Care Medicine at Rigshospitalet, Copenhagen, Denmark invites to the first interdisciplinary Copenhagen Critical Care Symposium. The target group are…

The annual meeting of the Swedish Anaesthesia and Intensive Care society will take place in Linköping, September 19th-21st this year. The honorary lectures will be…

SSAI follows the highest ethical standards and has a zero tolerance for all types of harassment including sexual harassment. The board of the SSAI has…

The SSAI board has gathered in Reykjavik, many new board members are welcomed and the new president of the SSAI Professor Klaus Olkkola introduced! Please…

SSAI has teamed up with the enthusiasts behind scanFOAM.org in order to provide the post- congress material of the 34th SSAI congress heldt in Malmø…

The first annual SSAI Research Methodology Course, Clinical trials will be held in April, 2018. This will be a 2 day (one overnight) course in Copenhagen Tuesday…

SSAI supports and urges for gender parity in all fields of Anaesthesiology! Therefore, SSAI has contributed to a recently published paper on gender parity in…